Gu, K., Kang, T. W., Shin, J., Sinn, D. H., Goh, M. J., Hong, J. Y., Chi, S. (2026). Prognostic factors in first-line atezolizumab-bevacizumab treatment of intermediate or advanced hepatocellular carcinoma. PLoS ONE. https://doi.org/10.1371/journal.pone.0354176